CDKN2A and penile cancer: P16INK4A has presently been used as an alternative marker of high-oncogenic risk HPV infection in cervical and other carcinomas [12], and some studies have shown that p16INK4a overexpression in penile cancers is associated with HPV infection [20, 21].